Focus
Drug Discovery Investors: Angels and VC Firms
The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.
Strongest in New York, San Francisco and Boston
- 4,683
- Drug Discovery investors
- 239
- Angel investors
- 4,444
- People at VC/PE firms
- 1,313
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
4,683 Drug Discovery investors
Showing 101-120
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
 Mark McLean Head of Asia Pacific at Morgan Stanley | Melbourne, Australia | Corporate VCPrivate equity | FinTechHardware | View profile | |
 Christopher Tracy Investor at Thynk Ventures | Orlando, United States | Venture capital | AIClimate | View profile | |
 Claire Smilow Partner at BoxGroup | New York, United States | Venture capital | AICommerce | View profile | |
 Kathy Meserve Investor at North Carolina Biotechnology Center | Cary, United States | AcceleratorGovernment-backed | EducationHealthcare | View profile | |
 Claire Brown Partner at Oxford Science Enterprises | United Kingdom | AcceleratorVenture capital | AIClimate | View profile | |
 Derek DiRocco Partner at RA Capital Management | Boston, United States | Private equityVenture capital | FinTechHealthcare | View profile | |
 Anurag Kondapalli Principal at RA Capital Management | New York, United States | Private equityVenture capital | FinTechHealthcare | View profile | |
 David Fawcett Affiliated at Epic Capital | Toronto, Canada | Corporate VCPrivate equity | AIHardware | View profile | |
 Niklas Windmann Principal at Gimv | Munich, Germany | Private equity | ClimateFood | View profile | |
 Tim Bliss Investor Relations & Finance at Teva Pharmaceuticals | United States | Corporate VC | Healthcare | View profile | |
 Peter M. Moglia Chief Executive Officer & Chief Investment Officer at Alexandria Real Estate Equities | Pasadena, United States | Corporate VC | HealthcareReal Estate | View profile | |
 Jean-Francois Pariseau Co-Founder and Partner at Amplitude Ventures | Montreal, Canada | Venture capital | AIHealthcare | View profile | |
 Mariana Mihalusova Investor at Venrock | San Francisco, United States | Private equityVenture capital | AICommerce | View profile | |
 John Williams Investor at Scvc | United Kingdom | Venture capital | AIClimate | View profile | |
 Sara Reis Investor at Frontier Ip Group | Lisbon, Portugal | Private equityVenture capital | AIClimate | View profile | |
 Leighton Read Venture Parter at Brandon Capital | Sausalito, United States | Venture capital | Healthcare | View profile | |
 Thomas Goudriaan Private Equity - Principal at Gimv | The Hague, Netherlands | Private equity | ClimateFood | View profile | |
 Andres Hurtado-Lorenzo Senior Vice President at Crohn's & Colitis Foundation | New York City, United States | Family Office | Healthcare | View profile | |
 Rebecca Silberman Investment Director at RA Capital Management | Cambridge, United States | Private equityVenture capital | FinTechHealthcare | View profile | |
 Jerry Liao Investor at Avego | New York City, United States | Private equityVenture capital | Healthcare | View profile |
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal